See more : NuCana plc (NCNA) Income Statement Analysis – Financial Results
Complete financial analysis of Veritas Farms, Inc. (VFRM) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Veritas Farms, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Zapf Creation AG (ZAPNF) Income Statement Analysis – Financial Results
- Qifeng New Material Co., Ltd. (002521.SZ) Income Statement Analysis – Financial Results
- Stryve Foods, Inc. (SNAXW) Income Statement Analysis – Financial Results
- Johnson Service Group PLC (JSVGF) Income Statement Analysis – Financial Results
- Zillow Group, Inc. Class C (Z) Income Statement Analysis – Financial Results
Veritas Farms, Inc. (VFRM)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.theveritasfarms.com
About Veritas Farms, Inc.
Veritas Farms, Inc. focuses on producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company's products include capsules, gummies, tinctures, lotions, salves, vape oils, cream, balm sticks, lip balms, and pet chews. It markets and sells its products under the Veritas Farms brand name, as well as through white label and private label custom formulations for distributors and retailers. The company was formerly known as SanSal Wellness Holdings, Inc. and changed its name to Veritas Farms, Inc. in February 2019. Veritas Farms, Inc. is based in Dania Beach, Florida.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.06M | 3.08M | 6.23M | 7.29M | 2.08M | 1.11M | 76.23K | 0.00 | 0.00 |
| Cost of Revenue | 2.45M | 4.11M | 3.27M | 3.83M | 1.20M | 923.26K | 521.50K | 32.56K | 0.00 |
| Gross Profit | -1.38M | -1.03M | 2.96M | 3.46M | 876.31K | 191.41K | -445.27K | -32.56K | 0.00 |
| Gross Profit Ratio | -130.11% | -33.30% | 47.51% | 47.46% | 42.13% | 17.17% | -584.09% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.05K | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 43.71K | 3.41K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.08M | 6.30M | 10.42M | 14.59M | 5.28M | 1.52M | 43.71K | 3.41K | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.08M | 6.30M | 10.42M | 14.59M | 5.28M | 1.52M | 43.71K | 6.46K | 0.00 |
| Cost & Expenses | 6.53M | 10.41M | 13.69M | 18.42M | 6.49M | 2.45M | 43.71K | 6.46K | 0.00 |
| Interest Income | 0.00 | 152.30K | 129.57K | 18.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 485.73K | 152.30K | 129.57K | 18.17K | 28.47K | 41.77K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 459.07K | 499.00K | 760.32K | 484.95K | 274.20K | 232.72K | 71.97K | -12.93K | 0.00 |
| EBITDA | -4.20M | -6.42M | -6.96M | -10.64M | -3.53M | -2.18M | -43.71K | -6.46K | 0.00 |
| EBITDA Ratio | -394.98% | -221.56% | -107.66% | -145.97% | -198.67% | -98.70% | -57.34% | 0.00% | 0.00% |
| Operating Income | -5.46M | -7.33M | -7.46M | -11.13M | -4.41M | -1.33M | 43.71K | 6.46K | 0.00 |
| Operating Income Ratio | -514.01% | -237.75% | -119.87% | -152.63% | -211.85% | -119.58% | 57.34% | 0.00% | 0.00% |
| Total Other Income/Expenses | 320.58K | 259.34K | -129.57K | -18.17K | 570.45K | -1.12M | 0.00 | -12.93K | 0.00 |
| Income Before Tax | -5.14M | -7.07M | -7.59M | -11.15M | -3.84M | -2.45M | -43.71K | -6.46K | 0.00 |
| Income Before Tax Ratio | -483.86% | -229.34% | -121.95% | -152.88% | -184.42% | -220.15% | -57.34% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 152.30K | 129.57K | 18.17K | -598.92K | 1.08M | 87.43K | 12.93K | 0.00 |
| Net Income | -5.14M | -7.22M | -7.72M | -11.17M | -3.84M | -2.45M | -43.71K | -6.46K | 0.00 |
| Net Income Ratio | -483.86% | -234.28% | -124.03% | -153.13% | -184.42% | -220.15% | -57.34% | 0.00% | 0.00% |
| EPS | -0.13 | -0.17 | -0.18 | -0.32 | -0.19 | -0.17 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.13 | -0.17 | -0.18 | -0.32 | -0.19 | -0.17 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 41.63M | 43.38M | 42.59M | 34.71M | 19.74M | 14.67M | 14.63M | 0.00 | 11.25M |
| Weighted Avg Shares Out (Dil) | 41.63M | 43.38M | 42.59M | 34.71M | 19.74M | 14.67M | 14.63M | 0.00 | 11.25M |
Veritas Farms Acquires ASYSTEM and ASYSTEM Labs as Part of Growth Strategy to Build the Next Generation of Innovative Wellness Brands
Veritas Farms Announces Securities Purchase Agreement, Resignation of Current CEO and Appointment of New CEO
Veritas Farms Announces Launch of Their New Sleep Support Product -- 1000mg Chamomile PM Tinctures
Source: https://incomestatements.info
Category: Stock Reports